Stimuli-sensitive nanopreparations for combination cancer therapy.

[1]  C. Gialeli,et al.  Roles of matrix metalloproteinases in cancer progression and their pharmacological targeting , 2011, The FEBS journal.

[2]  M. Repka,et al.  Matrix metalloproteinase-sensitive thermogelling polymer for bioresponsive local drug delivery. , 2011, Acta biomaterialia.

[3]  Kazunori Kataoka,et al.  Dendrimer phthalocyanine-encapsulated polymeric micelle-mediated photochemical internalization extends the efficacy of photodynamic therapy and overcomes drug-resistance in vivo. , 2011, Journal of controlled release : official journal of the Controlled Release Society.

[4]  Jun Gao,et al.  PEGylated fullerene/iron oxide nanocomposites for photodynamic therapy, targeted drug delivery and MR imaging. , 2013, Biomaterials.

[5]  V. Torchilin,et al.  Development of the novel PEG-PE-based polymer for the reversible attachment of specific ligands to liposomes: synthesis and in vitro characterization. , 2011, Bioconjugate chemistry.

[6]  K. Ng,et al.  Integrated hollow mesoporous silica nanoparticles for target drug/siRNA co-delivery. , 2013, Chemistry.

[7]  Paula T Hammond,et al.  Layer-by-layer nanoparticles for systemic codelivery of an anticancer drug and siRNA for potential triple-negative breast cancer treatment. , 2013, ACS nano.

[8]  Junsheng Liu,et al.  Formation of thermo-sensitive polyelectrolyte complex micelles from two biocompatible graft copolymers for drug delivery. , 2014, Journal of biomedical materials research. Part A.

[9]  Thomas L Andresen,et al.  Enzyme-triggered nanomedicine: Drug release strategies in cancer therapy (Invited Review) , 2010, Molecular membrane biology.

[10]  Chaoliang He,et al.  Co-delivery of 10-hydroxycamptothecin with doxorubicin conjugated prodrugs for enhanced anticancer efficacy. , 2013, Macromolecular bioscience.

[11]  R. Langer,et al.  Photoswitchable Nanoparticles for Triggered Tissue Penetration and Drug Delivery , 2012, Journal of the American Chemical Society.

[12]  T. Yin,et al.  cRGD-functionalized polymeric magnetic nanoparticles as a dual-drug delivery system for safe targeted cancer therapy. , 2013, Pharmacological research.

[13]  Yaping Li,et al.  Overcoming multidrug resistance by co-delivery of Mdr-1 and survivin-targeting RNA with reduction-responsible cationic poly(β-amino esters). , 2012, Biomaterials.

[14]  San-Yuan Chen,et al.  Enhancement of cancer therapy efficacy by trastuzumab-conjugated and pH-sensitive nanocapsules with the simultaneous encapsulation of hydrophilic and hydrophobic compounds. , 2014, Nanomedicine : nanotechnology, biology, and medicine.

[15]  C. Alexander,et al.  Stimuli responsive polymers for biomedical applications. , 2005, Chemical Society reviews.

[16]  G. Murphy The ADAMs: signalling scissors in the tumour microenvironment , 2008, Nature Reviews Cancer.

[17]  Afsaneh Lavasanifar,et al.  Traceable multifunctional micellar nanocarriers for cancer-targeted co-delivery of MDR-1 siRNA and doxorubicin. , 2011, ACS nano.

[18]  Laurence Raehm,et al.  Cancer therapy improvement with mesoporous silica nanoparticles combining targeting, drug delivery and PDT. , 2012, International journal of pharmaceutics.

[19]  Jean-Pierre Gillet,et al.  Mechanisms of multidrug resistance in cancer. , 2010, Methods in molecular biology.

[20]  Morteza Mahmoudi,et al.  Magnetic fluid hyperthermia: focus on superparamagnetic iron oxide nanoparticles. , 2011, Advances in colloid and interface science.

[21]  Lin Zhu,et al.  Stimulus-responsive nanopreparations for tumor targeting. , 2013, Integrative biology : quantitative biosciences from nano to macro.

[22]  D. Panagiotakos,et al.  Increased temperature of malignant urinary bladder tumors in vivo: the application of a new method based on a catheter technique. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[23]  L. Huang,et al.  Highly efficient DNA delivery mediated by pH-sensitive immunoliposomes. , 1989, Biochemistry.

[24]  R. Jain,et al.  Photodynamic therapy for cancer , 2003, Nature Reviews Cancer.

[25]  Adah Almutairi,et al.  Photochemical mechanisms of light-triggered release from nanocarriers. , 2012, Advanced drug delivery reviews.

[26]  N. P. Ulrih,et al.  Multifunctional superparamagnetic iron oxide nanoparticles: promising tools in cancer theranostics. , 2013, Cancer letters.

[27]  J. Foidart,et al.  Emerging roles of ADAM and ADAMTS metalloproteinases in cancer. , 2008, Biochimie.

[28]  Baorui Liu,et al.  Novel thermosensitive polymeric micelles for docetaxel delivery. , 2007, Journal of biomedical materials research. Part A.

[29]  Jianping Zhou,et al.  Redox-sensitive micelles self-assembled from amphiphilic hyaluronic acid-deoxycholic acid conjugates for targeted intracellular delivery of paclitaxel. , 2012, Biomaterials.

[30]  B. Al-Lazikani,et al.  Combinatorial drug therapy for cancer in the post-genomic era , 2012, Nature Biotechnology.

[31]  Zhiyuan Zhong,et al.  Glutathione-responsive nano-vehicles as a promising platform for targeted intracellular drug and gene delivery. , 2011, Journal of controlled release : official journal of the Controlled Release Society.

[32]  Joel A Swanson,et al.  Drug delivery strategy utilizing conjugation via reversible disulfide linkages: role and site of cellular reducing activities. , 2003, Advanced drug delivery reviews.

[33]  Makoto Takafuji,et al.  Gene delivery into human cancer cells by cationic lipid-mediated magnetofection. , 2013, International journal of pharmaceutics.

[34]  G. Salzano,et al.  Polymeric micelles containing reversibly phospholipid-modified anti-survivin siRNA: a promising strategy to overcome drug resistance in cancer. , 2014, Cancer letters.

[35]  J. Fox,et al.  ADAM 12-S cleaves IGFBP-3 and IGFBP-5 and is inhibited by TIMP-3. , 2000, Biochemical and biophysical research communications.

[36]  C. Janeway,et al.  Elevated temperature regulates tumor necrosis factor‐mediated immune killing , 1989, European journal of immunology.

[37]  Vladimir Torchilin,et al.  Multifunctional and stimuli-sensitive pharmaceutical nanocarriers. , 2009, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[38]  J. Karp,et al.  Nanocarriers as an Emerging Platform for Cancer Therapy , 2022 .

[39]  I. Safarik,et al.  Magnetic Nanoparticles and Biosciences , 2002 .

[40]  T. Okano,et al.  20. Multi-targeting system with fusion between thermoresponsive carriers and mild hyperthermia: Original research article: Thermo-responsive drug delivery from polymeric micelles constructed using block copolymers of poly(N-isopropylacrylamide) and poly(butylmethacrylate) (1999). , 2014, Journal of controlled release : official journal of the Controlled Release Society.

[41]  Chandana Mohanty,et al.  Dual drug loaded superparamagnetic iron oxide nanoparticles for targeted cancer therapy. , 2010, Biomaterials.

[42]  T. Andresen,et al.  Liposomes containing alkylated methotrexate analogues for phospholipase A(2) mediated tumor targeted drug delivery. , 2009, Chemistry and physics of lipids.

[43]  Kazuo Maruyama,et al.  Intracellular targeting delivery of liposomal drugs to solid tumors based on EPR effects. , 2011, Advanced drug delivery reviews.

[44]  L. Gerweck,et al.  Cellular pH gradient in tumor versus normal tissue: potential exploitation for the treatment of cancer. , 1996, Cancer research.

[45]  Ting-Chao Chou,et al.  Theoretical Basis, Experimental Design, and Computerized Simulation of Synergism and Antagonism in Drug Combination Studies , 2006, Pharmacological Reviews.

[46]  Liang Shen,et al.  Triplet excited state characters and photosensitization mechanisms of alpha-terthienyl: a theoretical study. , 2009, Journal of photochemistry and photobiology. B, Biology.

[47]  Yaping Li,et al.  Reversal of lung cancer multidrug resistance by pH-responsive micelleplexes mediating co-delivery of siRNA and paclitaxel. , 2014, Macromolecular bioscience.

[48]  A. Hoffman,et al.  Efficient Intracellular Delivery of a Pro-Apoptotic Peptide With A pH-Responsive Carrier. , 2011, Reactive & functional polymers.

[49]  S. Mallapragada,et al.  Injectable self-assembled block copolymers for sustained gene and drug co-delivery: an in vitro study. , 2012, International journal of pharmaceutics.

[50]  H. Uno,et al.  Zosuquidar, a novel modulator of P-glycoprotein, does not improve the outcome of older patients with newly diagnosed acute myeloid leukemia: a randomized, placebo-controlled trial of the Eastern Cooperative Oncology Group 3999. , 2010, Blood.

[51]  X. Jing,et al.  Co-delivery of daunomycin and oxaliplatin by biodegradable polymers for safer and more efficacious combination therapy. , 2012, Journal of controlled release : official journal of the Controlled Release Society.

[52]  Bonnie F. Sloane,et al.  Cathepsin B and its role(s) in cancer progression. , 2003, Biochemical Society symposium.

[53]  Liangfang Zhang,et al.  Nanoparticle-assisted combination therapies for effective cancer treatment. , 2010, Therapeutic delivery.

[54]  F. Kiessling,et al.  Drug targeting to tumors: principles, pitfalls and (pre-) clinical progress. , 2012, Journal of controlled release : official journal of the Controlled Release Society.

[55]  Benedict Law,et al.  Release of liposomal contents by cell-secreted matrix metalloproteinase-9. , 2009, Bioconjugate chemistry.

[56]  J. Foidart,et al.  Higher sensitivity of Adamts12-deficient mice to tumor growth and angiogenesis , 2010, Oncogene.

[57]  Bonnie F. Sloane,et al.  Cysteine cathepsins in human cancer , 2004, Biological chemistry.

[58]  G. Balendiran,et al.  The role of glutathione in cancer , 2004, Cell biochemistry and function.

[59]  Z. Werb,et al.  Matrix Metalloproteinases: Regulators of the Tumor Microenvironment , 2010, Cell.

[60]  P. Ruff,et al.  A randomized, placebo-controlled, double-blind phase 2 study of docetaxel compared to docetaxel plus zosuquidar (LY335979) in women with metastatic or locally recurrent breast cancer who have received one prior chemotherapy regimen , 2009, Cancer Chemotherapy and Pharmacology.

[61]  Vladimir P Torchilin,et al.  pH-sensitive poly(histidine)-PEG/DSPE-PEG co-polymer micelles for cytosolic drug delivery. , 2013, Biomaterials.

[62]  Vladimir P Torchilin,et al.  Immunomicelles for advancing personalized therapy. , 2012, Advanced drug delivery reviews.

[63]  Véronique Préat,et al.  To exploit the tumor microenvironment: Passive and active tumor targeting of nanocarriers for anti-cancer drug delivery. , 2010, Journal of controlled release : official journal of the Controlled Release Society.

[64]  Srinath Palakurthi,et al.  Hyaluronic acid-decorated PLGA-PEG nanoparticles for targeted delivery of SN-38 to ovarian cancer. , 2013, Anticancer research.

[65]  H. Gu,et al.  Delivering hydrophilic and hydrophobic chemotherapeutics simultaneously by magnetic mesoporous silica nanoparticles to inhibit cancer cells , 2012, International journal of nanomedicine.

[66]  R. Haag,et al.  Development of enzymatically cleavable prodrugs derived from dendritic polyglycerol. , 2009, Bioorganic & medicinal chemistry letters.

[67]  A. Hoffman,et al.  pH-sensitive polymers that enhance intracellular drug delivery in vivo. , 2002, Journal of controlled release : official journal of the Controlled Release Society.

[68]  Tae-Hyun Kim,et al.  Multifunctional hybrid nanocarrier: magnetic CNTs ensheathed with mesoporous silica for drug delivery and imaging system. , 2014, ACS applied materials & interfaces.

[69]  Yue Zhao Rational design of light-controllable polymer micelles. , 2007, Chemical record.

[70]  U. Sharma,et al.  Composite polymeric magnetic nanoparticles for co-delivery of hydrophobic and hydrophilic anticancer drugs and MRI imaging for cancer therapy. , 2011, ACS applied materials & interfaces.

[71]  I. Tannock,et al.  Acid pH in tumors and its potential for therapeutic exploitation. , 1989, Cancer research.

[72]  Stuart S Dunn,et al.  Reductively responsive siRNA-conjugated hydrogel nanoparticles for gene silencing. , 2012, Journal of the American Chemical Society.

[73]  Robert Blumenthal,et al.  A novel class of photo-triggerable liposomes containing DPPC:DC(8,9)PC as vehicles for delivery of doxorubcin to cells. , 2011, Biochimica et biophysica acta.

[74]  Andreas Herrmann,et al.  Reduction-sensitive liposomes from a multifunctional lipid conjugate and natural phospholipids: reduction and release kinetics and cellular uptake. , 2011, Langmuir : the ACS journal of surfaces and colloids.

[75]  G. Bothun,et al.  Stimuli-responsive liposome-nanoparticle assemblies , 2011, Expert opinion on drug delivery.

[76]  Q. Tong,et al.  Co-Delivery of Doxorubicin and SATB1 shRNA by Thermosensitive Magnetic Cationic Liposomes for Gastric Cancer Therapy , 2014, PloS one.

[77]  D. Hanahan,et al.  Hallmarks of Cancer: The Next Generation , 2011, Cell.

[78]  Z. Gan,et al.  Novel reduction-sensitive micelles for triggered intracellular drug release. , 2011, Journal of controlled release : official journal of the Controlled Release Society.

[79]  J. Ji,et al.  Near-infrared light-sensitive micelles for enhanced intracellular drug delivery , 2012 .

[80]  N. Zhang,et al.  The targeted co-delivery of DNA and doxorubicin to tumor cells via multifunctional PEI-PEG based nanoparticles. , 2013, Biomaterials.

[81]  P. Meers,et al.  Enzyme-activated targeting of liposomes. , 2001, Advanced drug delivery reviews.

[82]  R. Issels,et al.  Hyperthermia-induced targeting of thermosensitive gene carriers to tumors. , 2008, Human gene therapy.

[83]  K. Na,et al.  Endolysosomal environment-responsive photodynamic nanocarrier to enhance cytosolic drug delivery via photosensitizer-mediated membrane disruption. , 2013, Biomaterials.

[84]  Patrick Couvreur,et al.  Stimuli-responsive nanocarriers for drug delivery. , 2013, Nature materials.

[85]  Shirui Mao,et al.  Smart pH-sensitive and temporal-controlled polymeric micelles for effective combination therapy of doxorubicin and disulfiram. , 2013, ACS nano.

[86]  R. Zhuo,et al.  Thermo-triggered and biotinylated biotin-P(NIPAAm-co-HMAAm)-b-PMMA micelles for controlled drug release. , 2009, Journal of biomedical materials research. Part A.

[87]  Dibakar Dhara,et al.  Thermal and pH responsive polymer-tethered multifunctional magnetic nanoparticles for targeted delivery of anticancer drug. , 2013, ACS applied materials & interfaces.

[88]  Vladimir P. Torchilin,et al.  Challenges in Development of Targeted Liposomal Therapeutics , 2012, The AAPS Journal.

[89]  Freya Q. Schafer,et al.  Redox environment of the cell as viewed through the redox state of the glutathione disulfide/glutathione couple. , 2001, Free radical biology & medicine.

[90]  Dongin Kim,et al.  A virus-mimetic nanogel vehicle. , 2008, Angewandte Chemie.

[91]  C. van Nostrum,et al.  Triggered destabilisation of polymeric micelles and vesicles by changing polymers polarity: an attractive tool for drug delivery. , 2007, Journal of Controlled Release.

[92]  D. Thompson,et al.  Synthesis of acid-labile diplasmenyl lipids for drug and gene delivery applications. , 1999, Chemistry and physics of lipids.

[93]  William Y. Kim,et al.  Codelivery of VEGF siRNA and gemcitabine monophosphate in a single nanoparticle formulation for effective treatment of NSCLC. , 2013, Molecular therapy : the journal of the American Society of Gene Therapy.

[94]  W. Denny,et al.  Targeting of nanoparticles in cancer: drug delivery and diagnostics , 2011, Anti-cancer drugs.

[95]  Mark W. Dewhirst,et al.  Review Hyperthermia and liposomes , 1999 .

[96]  Ronit Satchi-Fainaro,et al.  Nano-sized polymers and liposomes designed to deliver combination therapy for cancer. , 2013, Current opinion in biotechnology.

[97]  T. Okano,et al.  Preparation and characterization of thermally responsive block copolymer micelles comprising poly(N-isopropylacrylamide-b-DL-lactide). , 1998, Journal of controlled release : official journal of the Controlled Release Society.

[98]  L. Huang,et al.  pH-sensitive immunoliposomes as an efficient and target-specific carrier for antitumor drugs. , 1986, Cancer research.

[99]  X. Shuai,et al.  Co-delivery of doxorubicin and siRNA with reduction and pH dually sensitive nanocarrier for synergistic cancer therapy. , 2014, Small.

[100]  H. Maeda,et al.  A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs. , 1986, Cancer research.

[101]  Shiroh Futaki,et al.  A pH-sensitive fusogenic peptide facilitates endosomal escape and greatly enhances the gene silencing of siRNA-containing nanoparticles in vitro and in vivo. , 2009, Journal of controlled release : official journal of the Controlled Release Society.

[102]  Weiqi Wang,et al.  Dual temperature/pH-sensitive drug delivery of poly(N-isopropylacrylamide-co-acrylic acid) nanogels conjugated with doxorubicin for potential application in tumor hyperthermia therapy. , 2011, Colloids and surfaces. B, Biointerfaces.

[103]  P. Workman,et al.  The combination of cytotoxic and molecularly targeted therapies - can it be done? , 2004 .

[104]  K. Kono,et al.  Thermosensitive polymer-modified liposomes. , 2001, Advanced drug delivery reviews.

[105]  M. Moses,et al.  Matrix metalloproteinases as novel biomarkers and potential therapeutic targets in human cancer. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[106]  Si-Shen Feng,et al.  Targeted co-delivery of docetaxel, cisplatin and herceptin by vitamin E TPGS-cisplatin prodrug nanoparticles for multimodality treatment of cancer. , 2013, Journal of controlled release : official journal of the Controlled Release Society.

[107]  O. Peulen,et al.  Nuclear delivery of a therapeutic peptide by long circulating pH-sensitive liposomes: benefits over classical vesicles. , 2011, International journal of pharmaceutics.

[108]  Zhiyuan Zhong,et al.  Dual and multi-stimuli responsive polymeric nanoparticles for programmed site-specific drug delivery. , 2013, Biomaterials.

[109]  Alberto Mantovani,et al.  Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability. , 2009, Carcinogenesis.

[110]  Ru Cheng,et al.  Acetal-linked paclitaxel prodrug micellar nanoparticles as a versatile and potent platform for cancer therapy. , 2013, Biomacromolecules.

[111]  T. Okano,et al.  Thermo-responsive drug delivery from polymeric micelles constructed using block copolymers of poly(N-isopropylacrylamide) and poly(butylmethacrylate). , 1999, Journal of controlled release : official journal of the Controlled Release Society.

[112]  V. Torchilin,et al.  Environment-responsive multifunctional liposomes. , 2010, Methods in molecular biology.

[113]  Angela C Cruciano,et al.  Redox-triggered contents release from liposomes. , 2008, Journal of the American Chemical Society.

[114]  T. Yap,et al.  Development of therapeutic combinations targeting major cancer signaling pathways. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[115]  Molly M Stevens,et al.  Enzyme-responsive nanoparticles for drug release and diagnostics. , 2012, Advanced drug delivery reviews.

[116]  James H. Doroshow,et al.  Utilizing targeted cancer therapeutic agents in combination: novel approaches and urgent requirements , 2010, Nature Reviews Drug Discovery.

[117]  F. Ungaro,et al.  Biodegradable core-shell nanoassemblies for the delivery of docetaxel and Zn(II)-phthalocyanine inspired by combination therapy for cancer. , 2013, Journal of controlled release : official journal of the Controlled Release Society.

[118]  Ashutosh Chilkoti,et al.  Targeted drug delivery by thermally responsive polymers. , 2002, Advanced drug delivery reviews.

[119]  F. Szoka,et al.  Acid-triggered transformation of diortho ester phosphocholine liposome. , 2006, Journal of the American Chemical Society.

[120]  M. Stack,et al.  Proteinase requirements of epidermal growth factor–induced ovarian cancer cell invasion , 1998, International journal of cancer.

[121]  Gert Storm,et al.  Polymeric Micelles in Anticancer Therapy: Targeting, Imaging and Triggered Release , 2010, Pharmaceutical Research.

[122]  Yolonda L Colson,et al.  Biologically Responsive Polymeric Nanoparticles for Drug Delivery , 2012, Advanced materials.

[123]  S. Ganta,et al.  A review of stimuli-responsive nanocarriers for drug and gene delivery. , 2008, Journal of controlled release : official journal of the Controlled Release Society.

[124]  D. S. Lee,et al.  Stimulus‐Sensitive Polymeric Nanoparticles and Their Applications as Drug and Gene Carriers , 2013, Advanced healthcare materials.

[125]  M. Tan,et al.  Targeting cellular metabolism to improve cancer therapeutics , 2013, Cell Death and Disease.

[126]  Omid C Farokhzad,et al.  Targeted polymeric therapeutic nanoparticles: design, development and clinical translation. , 2012, Chemical Society reviews.

[127]  Angel Ortega,et al.  Glutathione in Cancer Biology and Therapy , 2006, Critical reviews in clinical laboratory sciences.

[128]  S. Bhatia,et al.  Protease-triggered unveiling of bioactive nanoparticles. , 2008, Small.

[129]  D. Hwang,et al.  Phospholipase signalling networks in cancer , 2012, Nature Reviews Cancer.

[130]  P. Allavena,et al.  Cancer-related inflammation , 2008, Nature.

[131]  X. Qi,et al.  Enhancing cellular uptake of activable cell-penetrating peptide–doxorubicin conjugate by enzymatic cleavage , 2012, International journal of nanomedicine.

[132]  Sylvia Notenboom,et al.  Glutathione dysregulation and the etiology and progression of human diseases , 2009, Biological chemistry.

[133]  Manish Kohli,et al.  Nanoparticles for combination drug therapy. , 2013, ACS nano.

[134]  Lin Zhu,et al.  Matrix metalloprotease 2-responsive multifunctional liposomal nanocarrier for enhanced tumor targeting. , 2012, ACS nano.

[135]  I. Aoki,et al.  Hydrothermally synthesized PEGylated calcium phosphate nanoparticles incorporating Gd-DTPA for contrast enhanced MRI diagnosis of solid tumors. , 2014, Journal of controlled release : official journal of the Controlled Release Society.

[136]  T. Shimada,et al.  Impact of polyplex micelles installed with cyclic RGD peptide as ligand on gene delivery to vascular lesions , 2011, Gene Therapy.

[137]  K. Chennazhi,et al.  Dual drug encapsulated thermo-sensitive fibrinogen-graft-poly (N-isopropyl acrylamide) nanogels for breast cancer therapy. , 2014, Colloids and surfaces. B, Biointerfaces.

[138]  J. Arias,et al.  Drug targeting strategies in cancer treatment: an overview. , 2011, Mini reviews in medicinal chemistry.

[139]  D. Irvine,et al.  In vitro and in vivo mRNA delivery using lipid-enveloped pH-responsive polymer nanoparticles. , 2011, Molecular pharmaceutics.

[140]  K. Huh,et al.  Heparin-folate-retinoic acid bioconjugates for targeted delivery of hydrophobic photosensitizers. , 2013, Carbohydrate polymers.

[141]  Chi-Hwa Wang,et al.  Transferrin-conjugated magnetic silica PLGA nanoparticles loaded with doxorubicin and paclitaxel for brain glioma treatment. , 2013, Biomaterials.

[142]  Emily Waltz,et al.  It's official: biologics are pharma's darlings , 2014, Nature Biotechnology.

[143]  S. Davaran,et al.  Development of dual responsive nanocomposite for simultaneous delivery of anticancer drugs , 2014, Journal of drug targeting.

[144]  Ambika Bumb,et al.  Macromolecules, dendrimers, and nanomaterials in magnetic resonance imaging: the interplay between size, function, and pharmacokinetics. , 2010, Chemical reviews.

[145]  R. Zhuo,et al.  Theranostic GO-based nanohybrid for tumor induced imaging and potential combinational tumor therapy. , 2014, Small.

[146]  Paul H. Johnson,et al.  pH-responsive polymeric micelle carriers for siRNA drugs. , 2010, Biomacromolecules.

[147]  Xiaogang Qu,et al.  Bioresponsive hyaluronic acid-capped mesoporous silica nanoparticles for targeted drug delivery. , 2013, Chemistry.

[148]  Robert Langer,et al.  Nanoparticle delivery of cancer drugs. , 2012, Annual review of medicine.

[149]  V. S. Lin,et al.  A magnetic mesoporous silica nanoparticle-based drug delivery system for photosensitive cooperative treatment of cancer with a mesopore-capping agent and mesopore-loaded drug. , 2013, Nanoscale.

[150]  Chen Jiang,et al.  Tumor-targeting and microenvironment-responsive smart nanoparticles for combination therapy of antiangiogenesis and apoptosis. , 2013, ACS nano.

[151]  S. W. Kim,et al.  Paclitaxel-conjugated PEG and arginine-grafted bioreducible poly (disulfide amine) micelles for co-delivery of drug and gene. , 2012, Biomaterials.

[152]  Emanuel Fleige,et al.  Stimuli-responsive polymeric nanocarriers for the controlled transport of active compounds: concepts and applications. , 2012, Advanced drug delivery reviews.

[153]  T. Segura,et al.  Protease degradable tethers for controlled and cell-mediated release of nanoparticles in 2- and 3-dimensions. , 2010, Biomaterials.

[154]  M. Stevens,et al.  Enzyme‐Responsive Nanoparticle Systems , 2008 .

[155]  S. Biswas,et al.  Hypoxia-targeted siRNA delivery. , 2014, Angewandte Chemie.

[156]  Yue Zhao,et al.  Main-chain photoresponsive polymers with controlled location of light-cleavable units: from synthetic strategies to structural engineering , 2013 .

[157]  Changhui Li,et al.  Enzyme-responsive copper sulphide nanoparticles for combined photoacoustic imaging, tumor-selective chemotherapy and photothermal therapy. , 2013, Chemical communications.

[158]  F. Liu,et al.  Chemotherapeutic drug delivery to cancer cells using a combination of folate targeting and tumor microenvironment-sensitive polypeptides. , 2013, Biomaterials.

[159]  Po-Jung Chen,et al.  Core‐Shell Nanocapsules Stabilized by Single‐Component Polymer and Nanoparticles for Magneto‐Chemotherapy/Hyperthermia with Multiple Drugs , 2012, Advanced materials.

[160]  Sokindra Kumar,et al.  Nanoparticles-mediated drug delivery approaches for cancer targeting: a review , 2013, Journal of drug targeting.

[161]  K. Wooley,et al.  Poly(ethylene oxide)‐block‐Polyphosphoester‐graft‐Paclitaxel Conjugates with Acid‐Labile Linkages as a pH‐Sensitive and Functional Nanoscopic Platform for Paclitaxel Delivery , 2014, Advanced healthcare materials.

[162]  Vladimir P. Torchilin,et al.  Recent Trends in Multifunctional Liposomal Nanocarriers for Enhanced Tumor Targeting , 2013, Journal of drug delivery.

[163]  R. Costo,et al.  INSTITUTE OF PHYSICS PUBLISHING JOURNAL OF PHYSICS D: APPLIED PHYSICS , 2003 .

[164]  Duane D. Miller,et al.  Site-specific delivery of oligonucleotides to hepatocytes after systemic administration. , 2008, Bioconjugate chemistry.

[165]  S. Frokjaer,et al.  Phospholipase A2 Sensitive Liposomes for Delivery of Small Interfering RNA (siRNA) , 2007, Journal of liposome research.

[166]  Jun Li,et al.  Supramolecular self-assembly forming a multifunctional synergistic system for targeted co-delivery of gene and drug. , 2014, Biomaterials.

[167]  W. Degraff,et al.  Selective modulation of glutathione levels in human normal versus tumor cells and subsequent differential response to chemotherapy drugs. , 1986, Cancer research.

[168]  Jiaming Zhuang,et al.  Multi-stimuli responsive macromolecules and their assemblies. , 2013, Chemical Society reviews.

[169]  María J. Vicent,et al.  Combination therapy: opportunities and challenges for polymer-drug conjugates as anticancer nanomedicines. , 2009, Advanced drug delivery reviews.

[170]  P. Stayton,et al.  Thermosensitive liposomes modified with poly(N-isopropylacrylamide-co-propylacrylic acid) copolymers for triggered release of doxorubicin. , 2010, Biomacromolecules.

[171]  Ruth Duncan,et al.  Development of HPMA copolymer-anticancer conjugates: clinical experience and lessons learnt. , 2009, Advanced drug delivery reviews.

[172]  V. Torchilin,et al.  Matrix metalloproteinase 2-sensitive multifunctional polymeric micelles for tumor-specific co-delivery of siRNA and hydrophobic drugs. , 2014, Biomaterials.

[173]  Zheng Huang,et al.  A Review of Progress in Clinical Photodynamic Therapy , 2005, Technology in cancer research & treatment.

[174]  H. Padh,et al.  Organelle targeting: third level of drug targeting , 2013, Drug design, development and therapy.

[175]  Yun-Jaie Choi,et al.  Synergistic effects of Akt1 shRNA and paclitaxel-incorporated conjugated linoleic acid-coupled poloxamer thermosensitive hydrogel on breast cancer. , 2012, Biomaterials.

[176]  Fong-Yu Cheng,et al.  Near‐Infrared Light‐Responsive Intracellular Drug and siRNA Release Using Au Nanoensembles with Oligonucleotide‐Capped Silica Shell , 2012, Advanced materials.

[177]  Chih-Kuang Chen,et al.  Biodegradable cationic polymeric nanocapsules for overcoming multidrug resistance and enabling drug-gene co-delivery to cancer cells. , 2014, Nanoscale.

[178]  V. Torchilin,et al.  Enhanced anticancer activity of nanopreparation containing an MMP2-sensitive PEG-drug conjugate and cell-penetrating moiety , 2013, Proceedings of the National Academy of Sciences.

[179]  B. Sumerlin,et al.  Future perspectives and recent advances in stimuli-responsive materials , 2010 .